EPLAW PATENT BLOG

IT – ATK Race v. Fritschi

Posted: March 28th, 2019

ATK Race S.r.l. (“ATK Race”), the owner of the European patent no. EP 2.345.463 (“EP ‘463”), concerning a heel piece for an alpine ski attachment, brought an infringement action before the Court of Genoa against Fritschi AG Swiss Binfings (“Fritschi”), Nuovi Orizzonti s.a.s. of Rizzo Riccardo & C. (“Nuovi Orizzonti”) and Socrep S.r.l. (“Socrep”), which […]

READ MORE

IT – Saima v. Plexa, Holacheck and Securconsult

Posted: March 12th, 2019

Saima Sicurezza S.p.A. (“Saima”), a company active in the security sector, brought a patent infringement and unfair competition action before the Court of Milan against Plexa srl, Holacheck srl and Securconsult. The plaintiff is the owner of the Italian patent no. IT 1.396.496 (“IT ’496”), concerning a system for managing passenger access control in public […]

READ MORE

DE – Preliminary decision regarding the amount of security for enforcement

Posted: March 11th, 2019

Preliminary decision regarding the amount of security for enforcement – Higher Regional Court of Karlsruhe, partial judgment dated October 10, 2018, docket no. 6 U 82/18, reported by Sebastian Horlemann and Stefan Lieck, Bardehle Pagenberg In a preliminary decision, the Higher Regional Court of Karlsruhe deals with the question which facts are to be taken […]

READ MORE

UK – Coloplast v. MacGregor Healthcare

Posted: November 7th, 2018

Coloplast A/S v. MacGregor Healthcare Limited, UK Intellectual Property Enterprise Court, 24 October 2018, [2018] EWHC 2797 (IPEC) This is a first instance decision from the UK Intellectual Property Enterprise Court “IPEC” on the validity and infringement of European Patent (UK) 1 145 729. The patent claimed a ready-to-use urinary catheter assembly which is stored […]

READ MORE

FR – Novartis v. Teva – Valsartan / Amlodipine – € 13,000,000 advance on damages

Posted: June 11th, 2018

Preliminary injunction issued by a French court against Teva’s generic of Novartis’ Exforge anti-hypertensive drug (valsartan/amlodipine) plus €13,000,000 awarded as an advance on damages On 7 June 2018, the tribunal de grande instance of Paris (Judge Marie Courboulay) issued a preliminary injunction against Teva’s generic of Novartis’ anti-hypertensive drug Exforge (valsartan/amlodipine) on the basis of […]

READ MORE

DE – Sektionaltor II

Posted: May 23rd, 2018

German Federal Court of Justice on financial compensation of co-authorized persons with regard to patents, BGH, “Sektionaltor II” judgment of May 16, 2017 – Case X ZR 85/14 When assessing whether a claim for financial compensation of co-authorized persons is necessary with respect to the principle of material justice, the reasons why the claimant has […]

READ MORE

UK – GSK v. Wyeth

Posted: November 23rd, 2017

Glaxosmithkline UK Limited v Wyeth Holdings LLC, High Court, London, UK, 13 January 2017, Neutral Citation Number: [2017] EWHC 91 (Pat) This is a judgment from Henry Carr J on preliminary issues relating to the remedies available to Wyeth (referred to as its parent company, Pfizer) for infringement of its patent by GSK. The key […]

READ MORE

UK – OOO Abbott v. Design & Display

Posted: November 22nd, 2017

OOO Abbott and another v Design & Display Limited and another, Intellectual Property Enterprise Court, UK, 22 November 2017 The UK Intellectual Property Enterprise Court considered issues arising relating to a determination of an account of profits following an earlier finding that Design & Display had infringed Abbott’s patent for slatted display panels. The Court […]

READ MORE

IT – Supreme Court ruling on Punitive Damages

Posted: August 21st, 2017

The first days of the Italian summer saw the issuance of a landmark decision for the Italian legal framework. The Grand Chamber of the Italian Court of Cassation (Cass. Civ. SS. UU. 05.07.2017, no. 16601) ruled that it could be possible to obtain recognition – where necessary – and enforce in Italy foreign judgements which […]

READ MORE